An active metabolite of bupropion
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

S,S-hydroxy Bupropion (hydrochloride)

Item No. 35718

Technical Information
Formal Name
(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, monohydrochloride
CAS Number
106083-71-0
Synonyms
  • BUPOH
  • BW 306U
  • GW 353162A
  • Radafaxine
Molecular Formula
C13H18ClNO2 • HCl
Formula Weight
Purity
≥98%
A solid
SMILES
O[C@]1(C2=CC(Cl)=CC=C2)[C@@H](NC(C)(CO1)C)C.Cl
InChi Code
InChI=1S/C13H18ClNO2.ClH/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10;/h4-7,9,15-16H,8H2,1-3H3;1H/t9-,13+;/m0./s1
InChi Key
ORXTVTDGPVINDN-BTJVGWIPSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    S,S-hydroxy Bupropion is an active metabolite of the antidepressant bupropion.1,2 It is formed from bupropion by the cytochrome P450 (CYP) isoform CYP2B6.3 S,S-hydroxy Bupropion inhibits dopamine and norepinephrine but not serotonin (5-HT) reuptake in HEK293 cells expressing the human transporters (IC50s = 0.63, 0.241, and >100 µM, respectively).1 It is also an antagonist of α3β4-, α4β2-, α4β4-, and α1β1 subunit-containing nicotinic acetylcholine receptors (nAChRs; IC50s = 11, 3.3, 30, and 28 µM, respectively). S,S-hydroxy Bupropion inhibits nicotine-induced analgesia in the tail-flick and hot plate tests, hyperlocomotion, and hypothermia in mice (ED50s = 0.2, 1, 0.9, and 1.5 mg/kg, respectively). It substitutes for (+)-amphetamine in rats in a two-lever drug discrimination test (ED50 = 4.4 mg/kg).2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lukas, R.J., Muresan, A.Z., Damaj, M.I., et alSynthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: Aids to smoking cessation. J. Med. Chem. 53(12), 4731-4748 (2010).

    2. Bondarev, M.L., Bondareva, T.S., Young, R., et alBehavioral and biochemical investigations of bupropion metabolites. Eur. J. Pharmacol. 474(1), 85-93 (2003).

    3. Coles, R., and Kharasch, E.D. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes. Pharm. Res. 25(6), 1405-1411 (2008).